GlassScriptPhysician profile
Rodney B Young
NPI 1083663371
$11,410.64
in general payments reported to CMS, 2019-2025
14 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,913 · 2020: $1,130 · 2021: $1,948 · 2022: $1,713 · 2023: $1,831 · 2024: $1,656 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,381 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,380.67 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,717.17 | 2019-2022 | |
| Mentor Worldwide LLC | $3,357.35 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $1,633.29 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Integra Lifesciences Corporation | $628.20 | 2020-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $432.96 | 2020-2023 | |
| Tela Bio, INC. | $396.76 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Acera Surgical, INC. | $294.70 | 2022-2023 | Restrata Wound Matrix |
| Sanara Medtech INC. | $261.85 | 2024-2025 | Celleraterx, Celleraterx |
| Smith+Nephew, INC. | $248.70 | 2024-2025 | Grafix Pl, Stravix |
| Kci USA, INC. | $214.86 | 2019-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Kerecis Limited | $124.57 | 2022 | |
| Galderma Laboratories, L.P. | $60.04 | 2019-2021 | |
| Atricure, INC. | $21.67 | 2022 | |
| Misonix INC | $18.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.